XCUR
Exicure (XCUR)
$72
About Exicure (XCUR)
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Redwood City, CA.
Details
Daily high
$3.75
Daily low
$3.72
Price at open
$3.72
52 Week High
$12.65
52 Week Low
$3.10
Market cap
24.0M
Dividend yield
0.00%
Volume
3,882
Avg. volume
11,797
P/E ratio
-4.89
Exicure News
Details
Daily high
$3.75
Daily low
$3.72
Price at open
$3.72
52 Week High
$12.65
52 Week Low
$3.10
Market cap
24.0M
Dividend yield
0.00%
Volume
3,882
Avg. volume
11,797
P/E ratio
-4.89